Protagenic Therapeutics, Inc.
NEW YORK, NY / ACCESSWIRE / March 21, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a biopharmaceutical innovator, regained compliance with Nasdaq Listing Rule 5550(a)(2) as the closing bid price of shares of PTIX has remained above $1.00 per share for ten consecutive trading days. This resolves the issue of potential delisting from Nasdaq by May 19, 2024 that the company had been facing.
On Tuesday, November 21, 2023, the company received a deficiency letter from Nasdaq stating that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market, because it had not maintained a minimum bid price of $1.00 per share for 30 consecutive trading days. The Notification Letter stated that the company had 180 calendar days, or until May 19, 2024, to regain compliance by having a closing bid price of at least $1.00 per share for ten consecutive trading days. On March 19, 2024, the company received a formal notice from Nasdaq confirming that it has regained compliance with Listing Rule 5550(a)(2).
About Protagenic Therapeutics, Inc.:
Protagenic Therapeutics, Inc. (Nasdaq: PTIX) is committed to pioneering neuro-active peptides into therapeutics to mitigate stress-related disorders. For more information, visit www.protagenic.com.
About PT00114:
PT00114, a 41-amino-acid synthetic peptide, holds promise in treating various neuro-psychiatric conditions, including depression, anxiety, and PTSD. It operates with a novel mechanism, mirroring the active part of the natural brain hormone TCAP, thereby reducing circulating cortisol levels.
Forward-Looking Statements:
This press release contains forward-looking statements concerning Protagenic Therapeutics' product candidates and clinical trial plans. These statements are subject to various risks and uncertainties. Investors are urged to exercise caution and not place undue reliance on these forward-looking statements.
Company Contact:
Alexander K. Arrow, MD, CFA Chief Financial Officer Protagenic Therapeutics, Inc. 149 Fifth Ave, Suite 500, New York, NY 10010. Tel: 213-260-4342 Email: alex.arrow@protagenic.com
Investor Relations Contact:
Kirin M. Smith, President, PCG Advisory, Inc. 950 Third Avenue, Suite #2700, New York, NY 10022. Tel: 646-823-8656 Email: ksmith@pcgadvisory.com
SOURCE: Protagenic Therapeutics, Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Polaris Renewable Energy Announces Corporate and Bond Instrument Credit Rating8.11.2024 12:05:00 CET | Press release
TORONTO, ON / ACCESSWIRE / November 8, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") is pleased to announce that international credit rating agency S&P Global Ratings has assigned corporate credit and bond instrument ratings of BB- with Stable Outlook to Polaris. About Polaris Renewable Energy Inc. Polaris Renewable Energy Inc. is a Canadian publicly traded company engaged in the development, construction, acquisition, and operation of renewable energy projects in five countries in Latin America and the Caribbean. The Company's operations include a geothermal plant (~82 MW), four run-of river hydroelectric plants (~40 MW), three solar (photovoltaic) projects in operation (~35 MW) and one wind park (26 MW) following closing of the Puerto Rico acquisition. For more information, contact: Investor Relations Polaris Renewable Energy Inc. Phone: +1 647-245-7199 Email: info@PolarisREI.com SOURCE: Polaris Renewable Energy Inc. View the original press release on ac
MANAMAURI, the High-Quality Energy Drink Brand, Joins EastBridge Global Investments for Major International Expansion8.11.2024 10:00:00 CET | Press release
The acquisition will fuel Manamauri's global expansion with new production facilities, extended product lines, and a continued commitment to supporting emerging sports. BRUSSELS, BELGIUM / ACCESSWIRE / November 8, 2024 / MANAMAURI, the energy drink brand known for its commitment to high quality and smart pricing, has officially finalized an acquisition agreement with a subsidiary of EastBridge Global Investments. This strategic partnership empowers MANAMAURI to scale globally, remaining true to its founding values of exceptional product standards, accessibility, and support for emerging sports talent. MANAMAURI LOGO MANAMAURI LOGO "MANAMAURI was established with a clear mission: to deliver premium energy products with an intelligent pricing model, making quality accessible without compromising our values," shared a spokesperson for MANAMAURI. "We've managed to grow steadily while maintaining lean operations, focusing on efficient structures that keep unnecessary costs low. The success
Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards8.11.2024 03:00:00 CET | Press release
The regional accolade recognizes commitment to global expansion and customer support LANSDALE, PA / ACCESSWIRE / November 8, 2024 / Greene Tweed, a global leader in advanced materials and high-performance solutions, has been honored as the Nottinghamshire "Excellence in International Trade" recipient of the 2024 East Midlands Chamber Business Awards, which celebrate the achievement and resilience of companies throughout the region. The East Midlands Chamber plays a vital role in connecting, supporting, and championing businesses and communities across Derbyshire, Leicestershire and Nottinghamshire in the United Kingdom. The Nottinghamshire Business Awards recently celebrated outstanding achievements in the local business community, where winners across 13 categories were announced. The "Excellence in International Trade" award specifically recognizes local businesses that excel in overseas trade. As one of five finalists in the category, Greene Tweed was selected for its robust growth
Polaris Renewable Energy Announces Fixed Income Meetings8.11.2024 01:00:00 CET | Press release
TORONTO, ON / ACCESSWIRE / November 8, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") announces today that it has engaged Pareto Securities as lead manager to arrange a series of fixed income meetings with potential eligible investors. Subject to market conditions and acceptable terms, the Company may issue a rated five-year tenor green bond on a private placement basis. The use of proceeds would be used to refinance certain existing debt facilities, the acquisition of the Punta Lima wind farm in Puerto Rico and other investments in renewable energy assets. S&P Global Ratings is expected to provide corporate and instrument ratings. The contemplated bond would be issued under the Company's green finance framework with second-party opinion from Morningstar Sustainalytics. The bonds have not been and will not be qualified for distribution in any province or territory of Canada. Accordingly, the bonds may not be offered or sold within any such province or terri
Innodata Reports Third Quarter 2024 Results; Record 136% Revenue Growth Year-Over-Year7.11.2024 17:00:00 CET | Press release
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / INNODATA INC. (Nasdaq: INOD) today reported results for the third quarter ended September 30, 2024. Revenue of $52.2 million, 136% revenue growth year-over-year. Net income of $17.4 million, or $0.60 per basic share and $0.51 per diluted share, compared to net income of $0.4 million, or $0.01 per basic and diluted share, in the same period last year. Third quarter net income included a $5.6 million benefit as a result of recognizing a deferred tax asset that related to our accumulated net operating losses and other deferred expenses from prior periods. Adjusted EBITDA of $13.9 million, an increase of 337% from $3.2 million in the same period last year.* Cash, cash equivalents and short-term investments of $26.4 million at September 30, 2024 and $13.8 million at December 31, 2023. Guidance raised to between 88% and 92% year-over-year revenue growth for full year 2024. *Adjusted EBITDA is defined below. Jack Abuhoff, CEO, said "Innodata cont
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom